Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Nanorods Make a Stand

Published: Monday, June 13, 2011
Last Updated: Monday, June 13, 2011
Bookmark and Share
Utilizing an interesting seed-mediated approach ZnO nanorods were helped to “stand” vertically on microsubstrates.

An article published in CrystEngComm details how, taking ZnO nanosheets as the microsubstrates, ZnO nanorods can grow vertically, not lying horizontally, on the facets with the aid of a seed layer precoating to form hierarchical ZnO nanorod-nanosheet architectures. The diameter as well as the length of the standing nanorods can be controlled effectively by adjusting the growth time and the amount of ammonia in the growth solution. The precoated seed layer has been found to be the key factor in determining the resultant morphology.

Reproduced by permission from The Royal Society of Chemistry from CrystEngComm Blog at http://blogs.rsc.org/ce/


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Centrifuge-on-a-Chip and Next-Generation Integrated Microfluidics
A microfluidic chip that can mimic the functions of a centrifuge without moving parts or external forces has been designed by Dino Di Carlo and colleagues from the University of California, Los Angeles.
Wednesday, August 17, 2011
Aminoazines and their Affinity for Graphite
In this CrystEngComm Hot article James D. Wuest and co-workers from the University of Montréal, Canada, look at crystalline amino-substituted azines.
Monday, June 27, 2011
Exciting New Leads in the Fight against Malaria
Researchers from the University of Liverpool and the London and Liverpool Schools of Tropical Medicine have developed a new series of tetraoxane analogues and screened them for their in vitro and in vivo antimalarial activity.
Monday, June 27, 2011
Strategies in Organocatalysts Immobilisation
This review summarizes the successful application of non-covalent interactions, such as acid–base interaction, ion–pair interaction, hydrophobic interaction and so on, in assembling recoverable and reusable organocatalysts.
Friday, June 17, 2011
Drugs that go beyond the rule of five – or do they?
In this HOT paper, published in MedChemComm, researchers from Pfizer explore the influence of intramolecular hydrogen bonding on the membrane permeability and bioavailability of these drugs.
Friday, June 03, 2011
The Importance of Green Chemistry in Process Research and Development
Concern for our planet and its well being is forcing chemists to think about greener, more sustainable processes to make the things we need and want, such as new technologies, fuels and drugs.
Wednesday, June 01, 2011
Assembling Isoniazid
This paper, published in the journal CrystEngComm, describes how researchers have modified the hydrogen bonding in isonicotinic acid hydrazide (isoniazid) in order to control the self-assembly process.
Monday, May 23, 2011
ESR Spectroscopy as a tool to Investigate the Properties of Self-Assembled Monolayers Protecting Gold Nanoparticles
An Article published in Nanoscale details how researchers at the University of Bologna and the University of Trieste have used Electron spin resonance (ESR) spectroscopy technique to study the properties of metal nanoparticles.
Thursday, November 25, 2010
RSC Holds 5th Conference on High Throughput Medicinal Chemistry
The conference will explore technology-enabled drug discovery and new synthetic technologies, focusing medicinal chemistry on 12th May 2009 in Cheshire, UK.
Monday, May 04, 2009
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!